CHEMOIMMUNOTHERAPY FOR AGGRESSIVE VARIANT PROSTATE CANCERS (AVPC)

$2,498,000FY2020Defense Health AgencyDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators

View source on USAspending →